{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:20:16Z","timestamp":1789449616964,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":2214,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01-HL070241"],"award-info":[{"award-number":["R01-HL070241"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01-HL080682"],"award-info":[{"award-number":["R01-HL080682"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P20-GM103629"],"award-info":[{"award-number":["P20-GM103629"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30-GM103337"],"award-info":[{"award-number":["P30-GM103337"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U54-GM104940"],"award-info":[{"award-number":["U54-GM104940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1074\/jbc.m114.585521","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T00:25:24Z","timestamp":1407803124000},"page":"26239-26248","source":"Crossref","is-referenced-by-count":29,"title":["Angiotensin Type 2 Receptor Signaling in Satellite Cells Potentiates Skeletal Muscle Regeneration"],"prefix":"10.1016","volume":"289","author":[{"given":"Tadashi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tashfin S.","family":"Huq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Delafontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M114.585521_bib1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2165\/11537910-000000000-00000","article-title":"Optimal antagonism of the renin-angiotensin-aldosterone system: do we need dual or triple therapy?","volume":"70","author":"Werner","year":"2010","journal-title":"Drugs"},{"key":"10.1074\/jbc.M114.585521_bib2","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI118698","article-title":"Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism","volume":"97","author":"Brink","year":"1996","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M114.585521_bib3","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1210\/endo.142.4.8082","article-title":"Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I","volume":"142","author":"Brink","year":"2001","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.M114.585521_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI22324","article-title":"Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting","volume":"115","author":"Song","year":"2005","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M114.585521_bib5","doi-asserted-by":"crossref","first-page":"H1565","DOI":"10.1152\/ajpheart.00146.2010","article-title":"IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression","volume":"298","author":"Yoshida","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"10.1074\/jbc.M114.585521_bib6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1210\/en.2011-1764","article-title":"Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus","volume":"153","author":"Yoshida","year":"2012","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.M114.585521_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbrc.2011.04.122","article-title":"Angiotensin II induced catabolic effect and muscle atrophy are redox dependent","volume":"409","author":"Semprun-Prieto","year":"2011","journal-title":"Biochem. Biophys. Res. Comm"},{"key":"10.1074\/jbc.M114.585521_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/HYPERTENSIONAHA.111.174839","article-title":"Angiotensin II upregulates protein phosphatase 2C\u03b1 and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting","volume":"58","author":"Tabony","year":"2011","journal-title":"Hypertension"},{"key":"10.1074\/jbc.M114.585521_bib9","doi-asserted-by":"crossref","first-page":"e30276","DOI":"10.1371\/journal.pone.0030276","article-title":"Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy","volume":"7","author":"Rezk","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M114.585521_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bjc.6602725","article-title":"Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia","volume":"93","author":"Sanders","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1074\/jbc.M114.585521_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2005.02.007","article-title":"Angiotensin II directly inhibits protein synthesis in murine myotubes","volume":"231","author":"Russell","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1074\/jbc.M114.585521_bib12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.biocel.2012.07.028","article-title":"Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor \u03b2 1 expression in skeletal muscle cells","volume":"44","author":"Morales","year":"2012","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1074\/jbc.M114.585521_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/euhj.1999.1740","article-title":"Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure","volume":"21","author":"Roig","year":"2000","journal-title":"Eur. Heart J"},{"key":"10.1074\/jbc.M114.585521_bib14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","article-title":"Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study","volume":"361","author":"Anker","year":"2003","journal-title":"Lancet"},{"key":"10.1074\/jbc.M114.585521_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/phrs.1998.0288","article-title":"Within-patient variability of hormone and cytokine concentrations in heart failure","volume":"37","author":"Masson","year":"1998","journal-title":"Pharmacol. Res"},{"key":"10.1074\/jbc.M114.585521_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MCO.0b013e328300ecc1","article-title":"Cachexia: prevalence and impact in medicine","volume":"11","author":"Tan","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1074\/jbc.M114.585521_bib17","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1161\/01.CIR.103.17.2195","article-title":"Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure","volume":"103","author":"Dalla Libera","year":"2001","journal-title":"Circulation"},{"key":"10.1074\/jbc.M114.585521_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2008060628","article-title":"IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting","volume":"20","author":"Zhang","year":"2009","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.M114.585521_bib19","doi-asserted-by":"crossref","first-page":"23823","DOI":"10.1074\/jbc.M112.449074","article-title":"Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration","volume":"288","author":"Yoshida","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.585521_bib20","series-title":"Regenerating the Heart","first-page":"173","author":"Yablonka-Reuveni","year":"2011"},{"key":"10.1074\/jbc.M114.585521_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blockade attenuates TGF-\u03b2-induced failure of muscle regeneration in multiple myopathic states","volume":"13","author":"Cohn","year":"2007","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M114.585521_bib22","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0363546508315470","article-title":"Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle","volume":"36","author":"Bedair","year":"2008","journal-title":"Am. J. Sports Med"},{"key":"10.1074\/jbc.M114.585521_bib23","doi-asserted-by":"crossref","first-page":"e15212","DOI":"10.1371\/journal.pone.0015212","article-title":"Regulation of muscle satellite cell activation and chemotaxis by angiotensin II","volume":"5","author":"Johnston","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M114.585521_bib24","doi-asserted-by":"crossref","first-page":"R321","DOI":"10.1152\/ajpregu.00007.2012","article-title":"Disruption of muscle renin-angiotensin system in AT1a\u2212\/\u2212 mice enhances muscle function despite reducing muscle mass but compromises repair after injury","volume":"303","author":"Murphy","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"key":"10.1074\/jbc.M114.585521_bib25","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1074\/jbc.M209879200","article-title":"Highly coordinated gene regulation in mouse skeletal muscle regeneration","volume":"278","author":"Yan","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.585521_bib26","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1126\/science.1087573","article-title":"Notch-mediated restoration of regenerative potential to aged muscle","volume":"302","author":"Conboy","year":"2003","journal-title":"Science"},{"key":"10.1074\/jbc.M114.585521_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1534-5807(02)00254-X","article-title":"The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis","volume":"3","author":"Conboy","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1074\/jbc.M114.585521_bib28","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1021\/jm00115a014","article-title":"Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype","volume":"34","author":"Blankley","year":"1991","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M114.585521_bib29","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1038\/mtna.2012.1","article-title":"Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation","volume":"1","author":"Broderick","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1074\/jbc.M114.585521_bib30","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1126\/science.278.5341.1288","article-title":"Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases","volume":"278","author":"Bennett","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.M114.585521_bib31","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1073\/pnas.92.23.10663","article-title":"The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer","volume":"92","author":"Nakajima","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.585521_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/10739680500301664","article-title":"Localization of the renin-angiotensin system components to the skeletal muscle microcirculation","volume":"12","author":"Agoudemos","year":"2005","journal-title":"Microcirculation"},{"key":"10.1074\/jbc.M114.585521_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1470320310381795","article-title":"Skeletal muscle myoblasts possess a stretch-responsive local angiotensin signalling system","volume":"12","author":"Johnston","year":"2011","journal-title":"J. Renin Angiotensin Aldosterone Syst"},{"key":"10.1074\/jbc.M114.585521_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.peptides.2013.10.022","article-title":"Angiotensin 1\u20137 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo","volume":"51","author":"Echeverr\u00eda-Rodr\u00edguez","year":"2014","journal-title":"Peptides"},{"key":"10.1074\/jbc.M114.585521_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbrc.2012.08.093","article-title":"ANG-(1\u20137) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle","volume":"426","author":"Prasannarong","year":"2012","journal-title":"Biochem. Biophys. Res. Comm"},{"key":"10.1074\/jbc.M114.585521_bib36","doi-asserted-by":"crossref","first-page":"e93449","DOI":"10.1371\/journal.pone.0093449","article-title":"ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis","volume":"9","author":"Riquelme","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M114.585521_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/biof.1087","article-title":"Transforming growth factor type \u03b2 1","volume":"39","author":"Painemal","year":"2013","journal-title":"BioFactors"},{"key":"10.1074\/jbc.M114.585521_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology: XXIII: The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev"},{"key":"10.1074\/jbc.M114.585521_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1152\/physiolgenomics.2000.2.1.13","article-title":"Inflammation influences vascular remodeling through AT2 receptor expression and signaling","volume":"2","author":"Akishita","year":"2000","journal-title":"Physiol. Genomics"},{"key":"10.1074\/jbc.M114.585521_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI1885","article-title":"Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects","volume":"101","author":"Masaki","year":"1998","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M114.585521_bib41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bjp.0705448","article-title":"Angiotensin AT2 receptors: cardiovascular hope or hype?","volume":"140","author":"Widdop","year":"2003","journal-title":"Br. J. Pharmacol"},{"key":"10.1074\/jbc.M114.585521_bib42","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1096\/fj.02-1193fje","article-title":"Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-\u03baB","volume":"17","author":"Reinecke","year":"2003","journal-title":"FASEB J"},{"key":"10.1074\/jbc.M114.585521_bib43","doi-asserted-by":"crossref","first-page":"PE16","DOI":"10.1126\/stke.2003.181.pe16","article-title":"Angiotensin type 2 receptor (AT2R): a challenging twin","volume":"2003","author":"Berk","year":"2003","journal-title":"Sci. STKE"},{"key":"10.1074\/jbc.M114.585521_bib44","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.peptides.2005.03.010","article-title":"The AT2 receptor: a matter of love and hate","volume":"26","author":"Steckelings","year":"2005","journal-title":"Peptides"},{"key":"10.1074\/jbc.M114.585521_bib45","doi-asserted-by":"crossref","first-page":"10436","DOI":"10.1074\/jbc.273.17.10436","article-title":"Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells","volume":"273","author":"Gredinger","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.585521_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0","article-title":"ERK1\/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion","volume":"186","author":"Jones","year":"2001","journal-title":"J. Cell Physiol"},{"key":"10.1074\/jbc.M114.585521_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1083\/jcb.200408066","article-title":"The p38\u03b1\/\u03b2 MAPK functions as a molecular switch to activate the quiescent satellite cell","volume":"169","author":"Jones","year":"2005","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.M114.585521_bib48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/01.RES.76.5.693","article-title":"Expression, genomic organization, and transcription of the mouse angiotensin II type 2 receptor gene","volume":"76","author":"Ichiki","year":"1995","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M114.585521_bib49","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/01.HYP.25.4.720","article-title":"Transcriptional regulation of the mouse angiotensin II type 2 receptor gene","volume":"25","author":"Ichiki","year":"1995","journal-title":"Hypertension"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820484558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820484558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M114.585521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:20:52Z","timestamp":1746332452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820484558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":49,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0021925820484558"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m114.585521","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}